IPOPLUS

1,131

-8 -0.70%

17 Jun 2026

NSE Listed

Epigral Limited (EPIGRAL)

Volume: 34,947Avg Vol 1W: 30,861Avg Vol 1M: 29,732.252W Range:8072,114
₹1,131 0.70%
Key Ratios
Updated 4h ago
Market Cap₹4,810 Cr
Current Price₹1,131
Previous Close₹1,139
High / Low (52w)₹2,114 / ₹807
Volume34,947
Avg Vol (1W)30,861
Avg Vol (1M)29,732.2
Stock P/E59.45
Book Value₹514.94
Dividend Yield0.5%
ROE14.9%
ROA9.5%
Revenue (TTM)₹2,542 Cr
Revenue Growth-0.9%
Profit Margin13.1%
Total Debt₹334 Cr
Shares Outstanding4 Cr
Face Value₹10
EPS (TTM)₹18.76
P/B2.17
Debt / Equity0.26
50 DMA₹1,184.12
200 DMA₹1,310.09
Day change-0.70%
Price Chart
1,131 36.64% · 1Y
20908138.4L
2025-06-17
2026-06-12

20-day avg volume: 30K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Revenue fell 26% YoY.
  • Stock trades at a high P/E of 59.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹651 Cr₹626 Cr₹645 Cr₹628 Cr₹607 Cr₹587 Cr₹597 Cr₹736 Cr
EBITDA₹145 Cr₹152 Cr₹153 Cr₹143 Cr₹130 Cr₹92 Cr₹66 Cr₹126 Cr
Net Profit₹86 Cr₹81 Cr₹104 Cr₹87 Cr₹161 Cr₹51 Cr₹39 Cr₹81 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹613 Cr₹831 Cr₹1,555 Cr₹2,196 Cr₹1,936 Cr₹2,565 Cr₹2,542 Cr
EBITDA₹152 Cr₹190 Cr₹428 Cr₹588 Cr₹364 Cr₹593 Cr₹414 Cr
Net Profit₹112 Cr₹101 Cr₹253 Cr₹353 Cr₹196 Cr₹358 Cr₹332 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹1,273 Cr₹1,449 Cr₹2,124 Cr₹2,432 Cr₹2,794 Cr₹3,152 Cr₹3,505 Cr
Total Liabilities₹690 Cr₹765 Cr₹1,398 Cr₹1,363 Cr₹1,540 Cr₹1,248 Cr₹1,284 Cr
Equity₹583 Cr₹684 Cr₹726 Cr₹1,069 Cr₹1,254 Cr₹1,905 Cr₹2,221 Cr
Total Debt₹418 Cr₹340 Cr₹557 Cr₹435 Cr₹492 Cr₹449 Cr₹334 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹258 Cr₹344 Cr₹734 Cr₹448 Cr₹551 Cr₹508 Cr
Investing₹-197 Cr₹-455 Cr₹-437 Cr₹-401 Cr₹-262 Cr₹-355 Cr
Financing₹-32 Cr₹195 Cr₹-200 Cr₹-8 Cr₹-164 Cr₹-94 Cr
Free Cash Flow₹258 Cr₹344 Cr₹734 Cr₹448 Cr₹551 Cr₹508 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search